Compare HTLD & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HTLD | CMPS |
|---|---|---|
| Founded | 1978 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 738.1M | 724.5M |
| IPO Year | 1995 | 2020 |
| Metric | HTLD | CMPS |
|---|---|---|
| Price | $10.88 | $5.83 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $10.00 | ★ $26.57 |
| AVG Volume (30 Days) | 296.8K | ★ 1.9M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.73% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $805,709,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.63 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.00 | $2.25 |
| 52 Week High | $12.13 | $8.90 |
| Indicator | HTLD | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 59.74 | 48.32 |
| Support Level | $10.66 | $4.90 |
| Resistance Level | $11.54 | $7.02 |
| Average True Range (ATR) | 0.30 | 0.29 |
| MACD | 0.12 | 0.06 |
| Stochastic Oscillator | 69.47 | 95.51 |
Heartland Express Inc, along with its subsidiaries, operates as a short, medium, and long-haul truckload carrier and transportation services provider. It mainly provides nationwide asset-based dry van truckload service for shippers across the United States, along with cross-border freight and other transportation services offered through third-party partnerships in Mexico. The group operates under the brand names of Heartland Express, Millis Transfer, Smith Transport, and CFI (for services within Mexico).
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.